AAAAAA

   
Results: 1-25 | 26-28
Results: 1-25/28
A PHASE-II TRIAL OF OUTPATIENT SUBCUTANEOUS GM-CSF, INTERLEUKIN-2, AND INTERFERON-ALPHA PLUS ORAL CIS-RETINOIC ACID IN PATIENTS WITH METASTATIC RENAL-CELL CANCER
Authors: RYAN CW VOGELZANG NJ DUMAS MC STADLER WM
Citation: Cw. Ryan et al., A PHASE-II TRIAL OF OUTPATIENT SUBCUTANEOUS GM-CSF, INTERLEUKIN-2, AND INTERFERON-ALPHA PLUS ORAL CIS-RETINOIC ACID IN PATIENTS WITH METASTATIC RENAL-CELL CANCER, Journal of investigative medicine, 46(7), 1998, pp. 274-274
PHASE-II AND PHARMACODYNAMIC STUDIES OF PYRAZINE DIAZOHYDROXIDE (NSC-361456) IN PATIENTS WITH ADVANCED RENAL AND COLORECTAL-CANCER
Authors: VOGELZANG NJ MANI S SCHILSKY RL ANSARI RH TABER D RHINEHART SN GARCIA JC MEYER SC MICK R BROCKSTEIN BE STADLER WM RATAIN MJ VOKES EE
Citation: Nj. Vogelzang et al., PHASE-II AND PHARMACODYNAMIC STUDIES OF PYRAZINE DIAZOHYDROXIDE (NSC-361456) IN PATIENTS WITH ADVANCED RENAL AND COLORECTAL-CANCER, Clinical cancer research, 4(4), 1998, pp. 929-934
PHASE-II AND PHARMACODYNAMIC STUDIES OF PYRAZINE DIAZOHYDROXIDE (NSC-361456) IN PATIENTS WITH ADVANCED RENAL AND COLORECTAL-CANCER
Authors: VOGELZANG NJ MANI S SCHILSKY RL ANSARI RH TABER D RHINEHART SN GARCIA JC MEYER SC MICK R BROCKSTEIN BE STADLER WM RATAIN MJ VOKES EE
Citation: Nj. Vogelzang et al., PHASE-II AND PHARMACODYNAMIC STUDIES OF PYRAZINE DIAZOHYDROXIDE (NSC-361456) IN PATIENTS WITH ADVANCED RENAL AND COLORECTAL-CANCER, Clinical cancer research, 4(4), 1998, pp. 929-934
ACTIVATED CALPHOSTIN-C CYTOTOXICITY IS INDEPENDENT OF P53 STATUS AND IN-VIVO METASTATIC POTENTIAL
Authors: DUBAUSKAS Z BECK TP CHMURA SJ KOVAR DA KADKHODAIAN MM SHRIVASTAV M CHUNG T STADLER WM RINKERSCHAEFFER CW
Citation: Z. Dubauskas et al., ACTIVATED CALPHOSTIN-C CYTOTOXICITY IS INDEPENDENT OF P53 STATUS AND IN-VIVO METASTATIC POTENTIAL, Clinical cancer research, 4(10), 1998, pp. 2391-2398
A PHASE-II STUDY OF 72 HOUR CONTINUOUS-INFUSION (CI) FLAVOPIRIDOL (FP) IN METASTATIC RENAL-CELL CARCINOMA (RCC)
Authors: STADLER WM LIEBOWITZ DN VOGELZANG NJ AMATO R SOSMAN J TABER D VOKES E
Citation: Wm. Stadler et al., A PHASE-II STUDY OF 72 HOUR CONTINUOUS-INFUSION (CI) FLAVOPIRIDOL (FP) IN METASTATIC RENAL-CELL CARCINOMA (RCC), Annals of oncology, 9, 1998, pp. 429-429
A PHASE-I TRIAL OF CONTINUOUS-INFUSION 5-FLUOROURACIL AND WEEKLY GEMCITABINE - UPDATED RESULTS OF AN ACTIVE COMBINATION FOR RENAL-CELL, HEPATOCELLULAR AND COLON-CARCINOMA
Authors: MANI S GORDON G VOGELZANG NJ BERTUCCI D SCHILSKY RL STADLER WM RATAIN MJ
Citation: S. Mani et al., A PHASE-I TRIAL OF CONTINUOUS-INFUSION 5-FLUOROURACIL AND WEEKLY GEMCITABINE - UPDATED RESULTS OF AN ACTIVE COMBINATION FOR RENAL-CELL, HEPATOCELLULAR AND COLON-CARCINOMA, Annals of oncology, 9, 1998, pp. 632-632
OVERCOMING CELLULAR SENESCENCE IN HUMAN CANCER PATHOGENESIS
Authors: YEAGER TR DEVRIES S JARRARD DF KAO CH NAKADA SY MOON TD BRUSKEWITZ R STADLER WM MEISNER LF GILCHRIST KW NEWTON MA WALDMAN FM REZNIKOFF CA
Citation: Tr. Yeager et al., OVERCOMING CELLULAR SENESCENCE IN HUMAN CANCER PATHOGENESIS, Genes & development, 12(2), 1998, pp. 163-174
MULTICENTER PHASE-II TRIAL OF INTERLEUKIN-2, INTERFERON-ALPHA, AND 13-CIS-RETINOIC ACID IN PATIENTS WITH METASTATIC RENAL-CELL CARCINOMA
Authors: STADLER WM KUZEL T DUMAS M VOGELZANG NJ
Citation: Wm. Stadler et al., MULTICENTER PHASE-II TRIAL OF INTERLEUKIN-2, INTERFERON-ALPHA, AND 13-CIS-RETINOIC ACID IN PATIENTS WITH METASTATIC RENAL-CELL CARCINOMA, Journal of clinical oncology, 16(5), 1998, pp. 1820-1825
KIDNEY CANCER
Authors: VOGELZANG NJ STADLER WM
Citation: Nj. Vogelzang et Wm. Stadler, KIDNEY CANCER, Lancet, 352(9141), 1998, pp. 1691-1696
CYTOKINE THERAPY IN METASTATIC RENAL-CANCER
Authors: STADLER WM VOGELZANG NJ
Citation: Wm. Stadler et Nj. Vogelzang, CYTOKINE THERAPY IN METASTATIC RENAL-CANCER, The New England journal of medicine, 339(12), 1998, pp. 849-849
OVERCOMING CELLULAR SENESCENCE IN HUMAN CANCER PATHOGENESIS
Authors: YEAGER TR REZNIKOFF CA JARRARD DF NAKADA SY MOON TD BRUSKEWITZ R STADLER WM MEISNER LF GILCHRIST KW NEWTON MA KAO CH DEVRIES S WALDMAN FM
Citation: Tr. Yeager et al., OVERCOMING CELLULAR SENESCENCE IN HUMAN CANCER PATHOGENESIS, The Journal of urology, 159(5), 1998, pp. 1102-1102
EXPRESSION OF BCL-2 AND BCL-X IN BLADDER-CANCER
Authors: KIRSH EJ BAUNOCH DA STADLER WM
Citation: Ej. Kirsh et al., EXPRESSION OF BCL-2 AND BCL-X IN BLADDER-CANCER, The Journal of urology, 159(4), 1998, pp. 1348-1353
CHROMOSOME 17-MEDIATED DORMANCY OF AT6.1 PROSTATE-CANCER MICROMETASTASES
Authors: CHEKMAREVA MA KADKHODAIAN MM HOLLOWELL CMP KIM H YOSHIDA BA LUU HH STADLER WM RINKERSCHAEFFER CW
Citation: Ma. Chekmareva et al., CHROMOSOME 17-MEDIATED DORMANCY OF AT6.1 PROSTATE-CANCER MICROMETASTASES, Cancer research, 58(21), 1998, pp. 4963-4969
GRANULOCYTE-MACROPHAGE-COLONY STIMULATING FACTOR IN METASTATIC RENAL-CELL CARCINOMA - A PHASE-II TRIAL
Authors: RINI BI STADLER WM SPIELBERGER RT RATAIN MJ VOGELZANG NJ
Citation: Bi. Rini et al., GRANULOCYTE-MACROPHAGE-COLONY STIMULATING FACTOR IN METASTATIC RENAL-CELL CARCINOMA - A PHASE-II TRIAL, Cancer, 82(7), 1998, pp. 1352-1358
METASTATIC BLADDER-CANCER - ADVANCES IN TREATMENT
Authors: STADLER WM KUZEL TM RAGHAVAN D LEVINE E VOGELZANG NJ ROTH B DORR FA
Citation: Wm. Stadler et al., METASTATIC BLADDER-CANCER - ADVANCES IN TREATMENT, European journal of cancer, 33, 1997, pp. 23-26
PHASE-II STUDY OF SINGLE-AGENT GEMCITABINE IN PREVIOUSLY UNTREATED PATIENTS WITH METASTATIC UROTHELIAL CANCER
Authors: STADLER WM KUZEL T ROTH B RAGHAVAN D DORR FA
Citation: Wm. Stadler et al., PHASE-II STUDY OF SINGLE-AGENT GEMCITABINE IN PREVIOUSLY UNTREATED PATIENTS WITH METASTATIC UROTHELIAL CANCER, Journal of clinical oncology, 15(11), 1997, pp. 3394-3398
LOSS OF THE CDKN2A P16 LOCUS DETECTED IN BLADDER IRRIGATION SPECIMENSBY FLUORESCENCE IN-SITU HYBRIDIZATION/
Authors: REEDER JE MORREALE JF OCONNELL MJ STADLER WM OLOPADE OF MESSING EM WHEELESS LL
Citation: Je. Reeder et al., LOSS OF THE CDKN2A P16 LOCUS DETECTED IN BLADDER IRRIGATION SPECIMENSBY FLUORESCENCE IN-SITU HYBRIDIZATION/, The Journal of urology, 158(5), 1997, pp. 1717-1721
THE 9P21 REGION IN BLADDER-CANCER CELL-LINES - LARGE HOMOZYGOUS DELETIONS INACTIVATE THE CDKN2, CDKN2B AND MTAP GENES
Authors: STADLER WM OLOPADE OI
Citation: Wm. Stadler et Oi. Olopade, THE 9P21 REGION IN BLADDER-CANCER CELL-LINES - LARGE HOMOZYGOUS DELETIONS INACTIVATE THE CDKN2, CDKN2B AND MTAP GENES, Urological research, 24(4), 1996, pp. 239-244
HIGH-DOSE CONTINUOUS INTRAVENOUS-INFUSION OF INTERLEUKIN-2 THERAPY FOR METASTATIC RENAL-CELL CARCINOMA - THE UNIVERSITY-OF-CHICAGO EXPERIENCE
Authors: SHULMAN KL STADLER WM VOGELZANG NJ
Citation: Kl. Shulman et al., HIGH-DOSE CONTINUOUS INTRAVENOUS-INFUSION OF INTERLEUKIN-2 THERAPY FOR METASTATIC RENAL-CELL CARCINOMA - THE UNIVERSITY-OF-CHICAGO EXPERIENCE, Urology, 47(2), 1996, pp. 194-197
URINARY NUCLEAR MATRIX PROTEIN AS A MARKER FOR TRANSITIONAL-CELL CARCINOMA OF THE URINARY-TRACT
Authors: CARPINITO GA STADLER WM BRIGGMAN JV CHODAK GW CHURCH PA LAMM DL LANGE PH MESSING EM PASCIAK RM RESERVITZ GB ROSS RN RUKSTALIS DB SAROSDY MF SOLOWAY MS THIEL RP VOGELZANG N HAYDEN CL
Citation: Ga. Carpinito et al., URINARY NUCLEAR MATRIX PROTEIN AS A MARKER FOR TRANSITIONAL-CELL CARCINOMA OF THE URINARY-TRACT, The Journal of urology, 156(4), 1996, pp. 1280-1285
USE OF A NEW TUMOR-MARKER, URINARY NMP22, IN THE DETECTION OF OCCULT OR RAPIDLY RECURRING TRANSITIONAL-CELL CARCINOMA OF THE URINARY-TRACT FOLLOWING SURGICAL-TREATMENT
Authors: SOLOWAY MS BRIGGMAN JV CARPINITO GA CHODAK GW CHURCH PA LAMM DL LANGE P MESSING E PASCIAK RM RESERVITZ GB RUKSTALIS DB SAROSDY MF STADLER WM THIEL RP HAYDEN CL
Citation: Ms. Soloway et al., USE OF A NEW TUMOR-MARKER, URINARY NMP22, IN THE DETECTION OF OCCULT OR RAPIDLY RECURRING TRANSITIONAL-CELL CARCINOMA OF THE URINARY-TRACT FOLLOWING SURGICAL-TREATMENT, The Journal of urology, 156(2), 1996, pp. 363-367
ELEVATED P16 AT SENESCENCE AND EOSS OF P16 AT IMMORTALIZATION IN HUMAN PAPILLOMAVIRUS-16 E6, BUT NOT E7, TRANSFORMED HUMAN UROEPITHELIAL CELLS
Authors: REZNIKOFF CA YEAGER TR BELAIR CD SAVELIEVA E PUTHENVEETTIL JA STADLER WM
Citation: Ca. Reznikoff et al., ELEVATED P16 AT SENESCENCE AND EOSS OF P16 AT IMMORTALIZATION IN HUMAN PAPILLOMAVIRUS-16 E6, BUT NOT E7, TRANSFORMED HUMAN UROEPITHELIAL CELLS, Cancer research, 56(13), 1996, pp. 2886-2890
LOW-DOSE INTERLEUKIN-2 IN THE TREATMENT OF METASTATIC RENAL-CELL CARCINOMA
Authors: STADLER WM VOGELZANG NJ
Citation: Wm. Stadler et Nj. Vogelzang, LOW-DOSE INTERLEUKIN-2 IN THE TREATMENT OF METASTATIC RENAL-CELL CARCINOMA, Seminars in oncology, 22(1), 1995, pp. 67-73
CONSTRUCTION OF A 2.8-MEGABASE YEAST ARTIFICIAL CHROMOSOME CONTIG ANDCLONING OF THE HUMAN METHYLTHIOADENOSINE PHOSPHORYLASE GENE FROM THE TUMOR-SUPPRESSOR REGION ON 9P21
Authors: OLOPADE OI POMYKALA HM HAGOS F SVEEN LW ESPINOSA R DREYLING MH GURSKY S STADLER WM LEBEAU MM BOHLANDER SK
Citation: Oi. Olopade et al., CONSTRUCTION OF A 2.8-MEGABASE YEAST ARTIFICIAL CHROMOSOME CONTIG ANDCLONING OF THE HUMAN METHYLTHIOADENOSINE PHOSPHORYLASE GENE FROM THE TUMOR-SUPPRESSOR REGION ON 9P21, Proceedings of the National Academy of Sciences of the United Statesof America, 92(14), 1995, pp. 6489-6493
A PHASE-II STUDY OF SUBCUTANEOUS RECOMBINANT HUMAN INTERLEUKIN-4 IN METASTATIC RENAL-CELL CARCINOMA
Authors: STADLER WM RYBAK ME VOGELZANG NJ
Citation: Wm. Stadler et al., A PHASE-II STUDY OF SUBCUTANEOUS RECOMBINANT HUMAN INTERLEUKIN-4 IN METASTATIC RENAL-CELL CARCINOMA, Cancer, 76(9), 1995, pp. 1629-1633
Risultati: 1-25 | 26-28